Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
107.3%
-
Total 13F principal
-
$471,355,027
-
Principal change
-
+$34,088,733
-
Total reported market value
-
$505,139,108
-
Number of holders
-
42
-
Value change
-
+$35,742,943
-
Number of buys
-
23
-
Number of sells
-
18
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q1 2017
As of 31 Mar 2017,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
42 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$471,355,027
in principal (par value) of the bond.
The largest 10 bondholders included
ZAZOVE ASSOCIATES LLC, PRUDENTIAL PLC, Allianz Asset Management GmbH, AXA, ADVENT CAPITAL MANAGEMENT /DE/, JPMORGAN CHASE & CO, VICTORY CAPITAL MANAGEMENT INC, Lombard Odier Asset Management (Europe) Ltd, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, and MACKAY SHIELDS LLC.
This page lists
42
institutional bondholders reporting positions
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.